Pheast Therapeutics

Pheast Therapeutics is a biotechnology company focused on developing cancer immunotherapies by targeting macrophage metabolism. Based on my training data, this appears to be a specialized biotech startup with limited public visibility beyond scientific and investment circles. The brand has moderate AI visibility within its niche biopharma context, with clearer understanding of its scientific focus than broad recognition or extensive content coverage. For users seeking information about emerging cancer immunotherapy companies, AI systems can provide basic details but lack comprehensive coverage.